SMITH ASSET MANAGEMENT GROUP LP - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$1,399,00082,1000.05%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders